Antonio Lazzaro

2.6k total citations
56 papers, 1.6k citations indexed

About

Antonio Lazzaro is a scholar working on Oncology, Hematology and Pathology and Forensic Medicine. According to data from OpenAlex, Antonio Lazzaro has authored 56 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Oncology, 17 papers in Hematology and 16 papers in Pathology and Forensic Medicine. Recurrent topics in Antonio Lazzaro's work include Lymphoma Diagnosis and Treatment (13 papers), Chronic Lymphocytic Leukemia Research (10 papers) and Multiple Myeloma Research and Treatments (10 papers). Antonio Lazzaro is often cited by papers focused on Lymphoma Diagnosis and Treatment (13 papers), Chronic Lymphocytic Leukemia Research (10 papers) and Multiple Myeloma Research and Treatments (10 papers). Antonio Lazzaro collaborates with scholars based in Italy, United States and Greece. Antonio Lazzaro's co-authors include Luigi Cavanna, Daniele Vallisa, Raffaella Bertè, Carlo Moroni, Vincenzo Guzzanti, Elisa Anselmi, Stefano Sacchi, Patrizia Bernuzzi, Elena Trabacchi and Antonio Gigante and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Antonio Lazzaro

51 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Antonio Lazzaro Italy	22	574	538	396	307	279	56	1.6k
Rainer Vormittag Austria	20	392 0.7×	970 1.8×	169 0.4×	144 0.5×	238 0.9×	37	2.5k
Mutlu Arat Türkiye	23	426 0.7×	919 1.7×	203 0.5×	98 0.3×	152 0.5×	128	1.7k
Theodore Wun United States	21	308 0.5×	562 1.0×	279 0.7×	212 0.7×	210 0.8×	42	2.4k
G J Mufti United Kingdom	24	244 0.4×	1.0k 1.9×	403 1.0×	158 0.5×	108 0.4×	69	1.7k
Lidia Gil Poland	17	413 0.7×	414 0.8×	170 0.4×	192 0.6×	78 0.3×	136	1.2k
Leena Laasonen Finland	26	533 0.9×	433 0.8×	326 0.8×	232 0.8×	148 0.5×	83	2.4k
Sung Hwa Bae South Korea	19	468 0.8×	382 0.7×	274 0.7×	291 0.9×	197 0.7×	101	1.2k
Daniele Vallisa Italy	23	727 1.3×	143 0.3×	111 0.3×	692 2.3×	361 1.3×	96	2.0k
S. Granqvist Sweden	21	363 0.6×	641 1.2×	84 0.2×	134 0.4×	294 1.1×	39	2.3k
J. O. Armitage United States	20	1.1k 1.9×	588 1.1×	176 0.4×	1.4k 4.6×	259 0.9×	54	2.5k

Countries citing papers authored by Antonio Lazzaro

Since Specialization

Citations

This map shows the geographic impact of Antonio Lazzaro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Antonio Lazzaro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Antonio Lazzaro more than expected).

Fields of papers citing papers by Antonio Lazzaro

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Antonio Lazzaro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Antonio Lazzaro. The network helps show where Antonio Lazzaro may publish in the future.

Co-authorship network of co-authors of Antonio Lazzaro

This figure shows the co-authorship network connecting the top 25 collaborators of Antonio Lazzaro. A scholar is included among the top collaborators of Antonio Lazzaro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Antonio Lazzaro. Antonio Lazzaro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Touzeau, Cyrille, Hanlon Sia, Sebastian Grosicki, et al.. (2025). Impact of tumor burden on the risk of cytokine release syndrome (CRS) in patients with multiple myeloma treated with elranatamab (ELRA) in combination with daratumumab (DARA) and lenalidomide (R) in the MagnetisMM-6 trial. Blood. 146(Supplement 1). 2283–2283.

Lucioni, Marco, Giuseppe Neri, Michele Merli, et al.. (2023). T-Cells Subsets in Castleman Disease: Analysis of 28 Cases Including Unicentric, Multicentric and HHV8-Related Clinical Forms. International Journal of Molecular Sciences. 24(9). 7813–7813. 6 indexed citations

Citterio, Chiara, et al.. (2021). Characteristics and outcomes of five patients with COVID‐19 and hematological malignancies. SHILAP Revista de lepidopterología. 9(6). e04013–e04013. 2 indexed citations

Falciglia, Francesco, Marco Giordano, Angelo Gabriele Aulisa, Antonio Lazzaro, & Vincenzo Guzzanti. (2014). Radial Neck Fractures in Children. Journal of Pediatric Orthopaedics. 34(8). 756–762. 42 indexed citations

Scarpioni, Roberto, Donato Rigante, Luca Cantarini, et al.. (2014). Renal involvement in secondary amyloidosis of Muckle-Wells syndrome: marked improvement of renal function and reduction of proteinuria after therapy with human anti-interleukin-1β monoclonal antibody canakinumab. Clinical Rheumatology. 34(7). 1311–1316. 28 indexed citations

Sacchi, Stefano, Raffaella Marcheselli, Antonio Lazzaro, et al.. (2011). A randomized trial with melphalan and prednisone versus melphalan and prednisone plus thalidomide in newly diagnosed multiple myeloma patients not eligible for autologous stem cell transplant. Leukemia & lymphoma. 52(10). 1942–1948. 23 indexed citations

Luminari, Stefano, Luigi Marcheselli, Stefano Sacchi, et al.. (2009). Anthracycline‐fludarabine‐containing regimens with or without rituximab in the treatment of patients with advanced follicular lymphoma. Cancer. 115(9). 1906–1913. 6 indexed citations

Sacchi, Stefano, Luigi Marcheselli, Alessia Bari, et al.. (2008). Secondary malignancies after treatment for indolent non-Hodgkin's lymphoma: a 16-year follow-up study. Haematologica. 93(3). 398–404. 65 indexed citations

Verso, Melina, Giancarlo Agnelli, Pieter W. Kamphuisen, et al.. (2008). Risk factors for upper limb deep vein thrombosis associated with the use of central vein catheter in cancer patients. Internal and Emergency Medicine. 3(2). 117–122. 84 indexed citations

10.

Federico, Massimo, Cesare Guglielmi, Stefano Luminari, et al.. (2007). Prognostic relevance of serum 2 microglobulin in patients with follicular lymphoma treated with anthracycline-containing regimens. A GISL study. Haematologica. 92(11). 1482–1488. 33 indexed citations

11.

Cavanna, Luigi, Antonio Lazzaro, Daniele Vallisa, Giuseppe Civardi, & Fabrizio Artioli. (2007). Role of image-guided fine-needle aspiration biopsy in the management of patients with splenic metastasis. World Journal of Surgical Oncology. 5(1). 13–13. 32 indexed citations

12.

Cavanna, Luigi, Fabrizio Artioli, Claudio Codignola, et al.. (2006). Oxaliplatin in Combination With 5-Fluorouracil (5-FU) and Leucovorin (LV) in Patients With Metastatic Gastric Cancer (MGC). American Journal of Clinical Oncology. 29(4). 371–375. 52 indexed citations

13.

Cavanna, Luigi, Giuseppe Civardi, Elisa Anselmi, et al.. (2005). Oncologic Emergencies Secondary to Advanced Colorectal Cancer Successfully Treated with Oxaliplatin/5-Fluorouracil/Leucovorin: Report of Three Cases. Journal of Chemotherapy. 17(3). 334–338.

14.

Morabito, Fortunato, Andrea Gallamini, Caterina Stelitano, et al.. (2004). Clinical relevance of immunophenotype in a retrospective comparative study of 297 peripheral T‐cell lymphomas, unspecified, and 496 diffuse large B‐cell lymphomas. Cancer. 101(7). 1601–1608. 38 indexed citations

15.

Civardi, Giuseppe, Daniele Vallisa, Raffaella Bertè, et al.. (2002). Focal liver lesions in non-Hodgkin's lymphoma: investigation of their prevalence, clinical significance and the role of Hepatitis C virus infection. European Journal of Cancer. 38(18). 2382–2387. 22 indexed citations

16.

Cavanna, Luigi, Raffaella Bertè, Antonio Lazzaro, et al.. (2002). Advanced Waldenström’s Macroglobulinemia: A Case of Possible Cure after Systemic Chemotherapy, Splenic Radiation and Splenectomy. Acta Haematologica. 108(2). 97–101. 5 indexed citations

17.

Bertè, Raffaella, Daniele Vallisa, Giuseppe Civardi, et al.. (2001). Rituximab in Combination with Interferon-Alpha in Relapsed and Refractory Diffuse Large B-Cell Non-Hodgkin’s Lymphoma. Acta Haematologica. 106(3). 141–142. 2 indexed citations

18.

Castagneto, B., Silvia Zai, Luciano Mutti, et al.. (2001). Palliative and therapeutic activity of IL-2 immunotherapy in unresectable malignant pleural mesothelioma with pleural effusion. Lung Cancer. 31(2-3). 303–310. 67 indexed citations

19.

Mutti, Luciano, Maria Teresa Valle, Bruno Balbi, et al.. (1998). Primary human mesothelioma cells express class II MHC, ICAM-1 and B7–2 and can present recall antigens to autologous blood lymphocytes. International Journal of Cancer. 78(6). 740–749. 32 indexed citations

20.

Pedrazzoli, Paolo, Gaetano Bergamaschi, Mario Cazzola, et al.. (1994). Effects of Granulocyte-Macrophage Colony-Stimulating Factor and Interleukin-3 on Small Cell Lung Cancer Cells. Cancer Investigation. 12(3). 283–288. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact